[
    [
        {
            "time": "2021-05-06",
            "original_text": "政策转向带崩疫苗板块，北向、机构、主力资金集体抛售疫苗股 股票卖空",
            "features": {
                "keywords": [
                    "政策转向",
                    "疫苗板块",
                    "北向资金",
                    "机构资金",
                    "主力资金",
                    "抛售"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "政策转向带崩疫苗板块，北向、机构、主力资金集体抛售疫苗股 股票卖空",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-06",
            "original_text": "疫苗板块遭遇重创，市场是否反应过度？",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "重创",
                    "市场反应"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗板块遭遇重创，市场是否反应过度？",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-06",
            "original_text": "公告精选：赣锋锂业拟要约收购海外锂项目公司；君正集团拟投建可降解塑料项目",
            "features": {
                "keywords": [
                    "赣锋锂业",
                    "要约收购",
                    "锂项目",
                    "君正集团",
                    "可降解塑料"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源",
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公告精选：赣锋锂业拟要约收购海外锂项目公司；君正集团拟投建可降解塑料项目",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-06",
            "original_text": "美国或将放弃新冠疫苗专利 复星医药股价过山车",
            "features": {
                "keywords": [
                    "美国",
                    "新冠疫苗",
                    "专利",
                    "复星医药",
                    "股价波动"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "美国或将放弃新冠疫苗专利 复星医药股价过山车",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-06",
            "original_text": "晚间重要公告2021年5月6日星期四",
            "features": {
                "keywords": [
                    "晚间公告",
                    "重要信息"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晚间重要公告2021年5月6日星期四",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-05-06",
            "original_text": "东莞证券维持复星医药谨慎推荐评级：美国开放专利影响有限，Q1主营业务持续恢复",
            "features": {
                "keywords": [
                    "东莞证券",
                    "复星医药",
                    "评级",
                    "美国专利",
                    "主营业务恢复"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东莞证券维持复星医药谨慎推荐评级：美国开放专利影响有限，Q1主营业务持续恢复",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]